This expansion is intended to eventually establish a novel research center named the Center for Mine Waste Biotechnology.

A pan-immunotherapy biomarker predicts and reactivates CD8⁺ T cell expansion, offering new insight into treatment response.

Non-invasive device worn on the forehead uses laser technology and an array of detectors, and could form the basis of methods for monitoring brain blood flow.

South Carolina’s fast-growing life sciences industry has sparked a partnership with the Massachusetts Biotechnology Council (MassBio), the industry group for the Bay State, aimed at nurturing startup ...

The findings explain how the brain implements visual working memory and why performance is both limited and variable.

CDMOs must now offer platform-based manufacturing, simplified tech transfers, AI-driven automation, and robust analytical services. Speed is also critical—traditional 18–24-month timelines are no ...

The company's multi-year strategy involves the rollout of new products and upgrades to existing ones that further strengthen its position.

The new technology delivers results in as little as 30 hours and reduces hands-on time by up to 40 percent, according to the company's data.

Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.

At ASHG in Boston, Eric Green received the society's Leadership Award and delivered an acceptance speech that moved the entire room.

Researchers now know that MS starts way earlier than the clinical onset, creating the real possibility that MS could one day be controlled.

Genomics unveils Mystra at ASHG 2025—an AI genetics platform to accelerate drug discovery and clinical validation using large-scale genetic data.